RVNC
Revance Therapeutics Inc
Price:
3.65
USD
Volume:
4,122,600
United States | Pharmaceuticals
RVNC Gross Margin
As of 2025-07-16, the Gross Margin of Revance Therapeutics Inc (RVNC) is 68.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
RVNC Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2023-12-31 | 68.2% |
| 2022-12-31 | 61% |
| 2021-12-31 | 69.9% |
| 2020-12-31 | 68.6% |
| 2019-12-31 | - |
| 2018-12-31 | - |
| 2017-12-31 | - |
| 2016-12-31 | - |
| 2015-12-31 | - |
| 2014-12-31 | - |
RVNC Gross Margin - Peers Comparison